Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Psychopharmacology (Berl). 2015 Nov 13;233(4):625–637. doi: 10.1007/s00213-015-4132-6

Table 5.

Hierarchical regression analysis predicting total distance traveled in response to the challenge day of treatment. Interactions were entered independently, such that interactions were tested then removed from the model. See Table 1’s description for the interpretation of R2, β, and t.

Step and predictor variable R2 β t
Step 1 .10
IEN −.08 0.44
NPP −.29 1.52
H-USV FM .05 0.27
Step 2 .49**
Repeated Low 0.3 mg/kg .32 1.50
Acute High 1.0 mg/kg .62 3.17**
Repeated High 1.0 mg/kg .83 3.56**
Step 3
Repeated Low 0.3 mg/kg × IEN .51 −.11 0.29
Acute High 1.0 mg/kg × IEN −.12 0.42
Repeated High 1.0 mg/kg × IEN .10 0.36
Repeated Low 0.3 mg/kg × NPP .50 −.18 0.59
Acute High 1.0 mg/kg × NPP −.08 0.24
Repeated High 1.0 mg/kg × NPP −.11 0.13
Repeated Low 0.3 mg/kg × H-USVFM .57 −.20 0.69
Acute High 1.0 mg/kg × H-USV FM −.14 0.66
Repeated High 1.0 mg/kg × H-USV FM .20 0.71
IEN × NPP .50 −.19 0.92
IEN × H-USV FM .48 .01 0.07
NPP × H-USV FM .48 −.05 0.24
*

p < .05;

**

p < .01;

***

p < .001